← All stocks

STAAR SURGICAL CO

STAA Net selling
CIK 0000718937 #2442 in the set updated 17 Sep 2026
Bought (120 mo)
$189.62M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$400.92M
$0.00 on a plan · $137.70M straight out of an exercise
Sold at will
$263.22M
94 of 164 sales
Net
−$211.30M
−$73.60M against sales at will

By person

28 insiders · 372 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BROADWOOD PARTNERS, L.P. entity
Director
$189.28M (166)
$245.60M (56)
−$56.32M
49,803,950
99.32%
$927.10M
+11.8%
Mason Caren L
President & CEO
$44.51M (13) scheduled
−$44.51M
152,415
0.3040%
$2.84M
+136.3%
Blickensdoerfer Hans-Martin
Sr. VP, Comm. Ops, China
$33.55M (18) scheduled
−$33.55M
83,110
0.1657%
$1.55M
−28.8%
Gesten Samuel J
Chief Legal Officer
$13.76M (8) scheduled
−$13.76M
43,665
0.0871%
$812.82K
+34.7%
Holliday Keith
Chief Technology Officer
$13.10M (19) scheduled
−$13.10M
28,157
0.0562%
$524.14K
−19.6%
Francese James E
Sr. VP, Comm. Ops., NA, APAC
$12.64M (13) scheduled
−$12.64M
42,660
0.0851%
$794.12K
+6.5%
Hayashida Jon K.
VP, Global Clinical, Medical
$10.72M (10) scheduled
−$10.72M
16,301
0.0325%
$303.44K
−23.6%
Moore John C
Director
$7.15M (1)
−$7.15M
2,117
0.0042%
$39.41K
−98.2%
SILVERMAN LOU
Director
$6.87M (4) scheduled
−$6.87M
12,658
0.0252%
$235.63K
−19.4%
Hansen Graydon C.
Sr. VP, Global Operations
$6.73M (11) scheduled
−$6.73M
9,801
0.0195%
$182.45K
−61.4%
ANDREWS DEBORAH J
Chief Financial Officer & EVP
$4.97M (7) scheduled
−$4.97M
38,910
0.0776%
$724.31K
Williams Patrick F.
Chief Financial Officer
$1.07M (2)
−$1.07M
56,242
0.1122%
$1.05M
Wall William P
Director
$206.75K (1)
−$206.75K
16,489
0.0329%
$306.94K
+37.1%
WEISNER AIMEE S
Director
$164.13K (2)
+$164.13K
15,352
0.0306%
$285.78K
Lin Elizabeth Yeu
Director
$100.00K (1)
+$100.00K
5,099
0.0102%
$94.92K
Barnes Scott D
Chief Medical Officer
$55.29K (1)
−$55.29K
41,502
0.0828%
$772.56K
+229.0%
Butcher Arthur C
Director
$49.96K (1)
+$49.96K
9,549
0.0190%
$177.75K
Zhou Lilian Yansheng
Director
$26.13K (1)
+$26.13K
8,101
0.0162%
$150.80K
Foust Warren
President and CEO
95,816
0.1911%
$1.78M
+2,384%
Jiang Wei
Director
77,127
0.1538%
$1.44M
FRINZI THOMAS G
President & CEO
70,519
0.1406%
$1.31M
Michna Magda
Chief Development Officer
41,343
0.0824%
$769.60K
FARRELL STEPHEN C
President & CEO
35,156
0.0701%
$654.43K
Studholme Robert
Senior VP, Operations
31,980
0.0638%
$595.31K
+49.4%
Brown Stephen P
VP, Chief Financial Officer
31,881
0.0636%
$593.46K
+42.0%
SISITSKY NATHANIEL
Chief Legal Officer
22,812
0.0455%
$424.65K
Kliman Gilbert H
Director
10,457
0.0209%
$194.66K
Yu K Peony
Director
2,786
0.0056%
$51.86K
Insider
Date
Role
Action
Shares
Price
Amount
Francese James E
27 Sep 2022
Sr. VP, Comm. Ops., NA, APAC
Sold after exercise
13,075
$75.00
$980.63K
Francese James E
27 Sep 2022
Sr. VP, Comm. Ops., NA, APAC
Sold after exercise
15,683
$75.00
$1.18M
Francese James E
27 Sep 2022
Sr. VP, Comm. Ops., NA, APAC
Sold after exercise
6,667
$75.00
$500.03K
Holliday Keith
15 Aug 2022
Chief Technology Officer
Sold after exercise
5,000
$106.22
$531.10K
Holliday Keith
15 Aug 2022
Chief Technology Officer
Sold after exercise
11,582
$106.32
$1.23M
Mason Caren L
20 May 2022
President & CEO
Sold after exercise
35,000
$58.48
$2.05M
Mason Caren L
19 May 2022
President & CEO
Sold after exercise
35,000
$57.49
$2.01M
Mason Caren L
18 May 2022
President & CEO
Sold after exercise
35,000
$56.46
$1.98M
Mason Caren L
18 Nov 2021
President & CEO
Sold after exercise
35,000
$113.83
$3.98M
Mason Caren L
17 Nov 2021
President & CEO
Sold after exercise
35,000
$113.83
$3.98M
Mason Caren L
16 Nov 2021
President & CEO
Sold after exercise
35,000
$114.20
$4.00M
Blickensdoerfer Hans-Martin
7 Sep 2021
Sr. VP, Comm. Ops, China
Sold after exercise
29,131
$157.40
$4.59M
Blickensdoerfer Hans-Martin
7 Sep 2021
Sr. VP, Comm. Ops, China
Sold after exercise
11,522
$157.40
$1.81M
Blickensdoerfer Hans-Martin
2 Sep 2021
Sr. VP, Comm. Ops, China
Sold after exercise
17,343
$157.50
$2.73M
Blickensdoerfer Hans-Martin
2 Sep 2021
Sr. VP, Comm. Ops, China
Sold after exercise
11,038
$157.50
$1.74M
Blickensdoerfer Hans-Martin
1 Sep 2021
Sr. VP, Comm. Ops, China
Sold after exercise
17,573
$157.61
$2.77M
Blickensdoerfer Hans-Martin
1 Sep 2021
Sr. VP, Comm. Ops, China
Sold after exercise
8,621
$157.61
$1.36M
Francese James E
18 Aug 2021
Sr. VP, Comm. Ops., NA, APAC
Sold after exercise
15,000
$146.91
$2.20M
Gesten Samuel J
12 Aug 2021
Chief Legal Officer
Sold after exercise
29,682
$134.71
$4.00M
SILVERMAN LOU
10 Aug 2021
Director
Sold after exercise
9,921
$145.54
$1.44M
SILVERMAN LOU
10 Aug 2021
Director
Sold after exercise
10,000
$145.56
$1.46M
SILVERMAN LOU
10 Aug 2021
Director
Sold after exercise
10,000
$145.57
$1.46M
Blickensdoerfer Hans-Martin
24 May 2021
Sr. VP, Comm. Ops, China
Sold after exercise
94,855
$130.42
$12.37M
Francese James E
24 May 2021
Sr. VP, Comm. Ops., NA, APAC
Sold after exercise
14,500
$130.42
$1.89M
Blickensdoerfer Hans-Martin
21 May 2021
Sr. VP, Comm. Ops, China
Sold after exercise
5,145
$128.00
$658.56K
Francese James E
21 May 2021
Sr. VP, Comm. Ops., NA, APAC
Sold after exercise
15,261
$126.83
$1.94M
Hansen Graydon C.
12 May 2021
Sr. VP, Global Operations
Sold after exercise
5,531
$110.74
$612.50K
Hansen Graydon C.
11 May 2021
Sr. VP, Global Operations
Sold after exercise
11,075
$111.61
$1.24M
Mason Caren L
11 May 2021
President & CEO
Sold after exercise
53,500
$110.70
$5.92M
Francese James E
10 May 2021
Sr. VP, Comm. Ops., NA, APAC
Sold after exercise
11,583
$125.72
$1.46M
Showing 250 of 372 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 321
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 44
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 70
Sales at will 94
Transactions with no price 0
Shares from compensation/vesting 3,426,585
Sales filed before the plan box existed 94
History held since 9 Dec 2016